Page last updated: 2024-10-16

carbon monoxide and Inflammatory Response Syndrome, Systemic

carbon monoxide has been researched along with Inflammatory Response Syndrome, Systemic in 11 studies

Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.

Research Excerpts

ExcerptRelevanceReference
"This study aimed to assess whether pretreatment with carbon monoxide-releasing molecule-2 (CORM-2) could ameliorate inflammation by regulating differentiation of CD4 + T cells in intestinal mucosa of rats undergoing hemorrhagic shock."8.12Carbon monoxide-releasing molecule 2 inhibits inflammation associated with intestinal ischemia-reperfusion injury in a rat model of hemorrhagic shock. ( Du, F; Niu, Q; Wang, X; Yang, X, 2022)
"Carbon monoxide-releasing molecule protected against hemorrhagic shock/resuscitation organ injury and systemic inflammation and reduced hepatic sinusoidal endothelial injury."7.81Carbon monoxide protects against hemorrhagic shock and resuscitation-induced microcirculatory injury and tissue injury. ( Brumfield, J; Escobar, D; Gallo, D; Gomez, H; Kautza, B; Loughran, P; Luciano, J; Nassour, I; Otterbein, LE; Rubin, M; Scott, J; Zuckerbraun, BS, 2015)
"This study aimed to assess whether pretreatment with carbon monoxide-releasing molecule-2 (CORM-2) could ameliorate inflammation by regulating differentiation of CD4 + T cells in intestinal mucosa of rats undergoing hemorrhagic shock."4.12Carbon monoxide-releasing molecule 2 inhibits inflammation associated with intestinal ischemia-reperfusion injury in a rat model of hemorrhagic shock. ( Du, F; Niu, Q; Wang, X; Yang, X, 2022)
"Carbon monoxide-releasing molecule protected against hemorrhagic shock/resuscitation organ injury and systemic inflammation and reduced hepatic sinusoidal endothelial injury."3.81Carbon monoxide protects against hemorrhagic shock and resuscitation-induced microcirculatory injury and tissue injury. ( Brumfield, J; Escobar, D; Gallo, D; Gomez, H; Kautza, B; Loughran, P; Luciano, J; Nassour, I; Otterbein, LE; Rubin, M; Scott, J; Zuckerbraun, BS, 2015)
"Hydrogen treatment alone significantly reduced malondialdehyde levels and serum high-mobility group box 1 protein levels as compared with air-treated controls."1.36Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both. ( Billiar, TR; Buchholz, BM; Cardinal, JS; Kaczorowski, DJ; Lee, S; McCurry, KR; Nakao, A; Sugimoto, R; Tobita, K; Toyoda, Y; Wang, Y, 2010)
"Patients with septic shock had significantly higher plasma CO concentrations than those without shock."1.32Carbon monoxide concentrations in paediatric sepsis syndrome. ( Jiang, D; Li, H; Pan, F; Pan, J; Qin, S; Shen, C; Shi, Y, 2003)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (63.64)29.6817
2010's3 (27.27)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Niu, Q3
Du, F3
Yang, X6
Wang, X3
Ji, X1
Pan, Z1
Li, C1
Kang, T1
De La Cruz, LKC1
Yang, L1
Yuan, Z1
Ke, B1
Wang, B1
Nassour, I1
Kautza, B1
Rubin, M1
Escobar, D1
Luciano, J1
Loughran, P1
Gomez, H1
Scott, J1
Gallo, D1
Brumfield, J1
Otterbein, LE1
Zuckerbraun, BS1
Scott, JR1
Cukiernik, MA1
Ott, MC1
Bihari, A1
Badhwar, A1
Gray, DK1
Harris, KA1
Parry, NG1
Potter, RF1
Nakao, A1
Kaczorowski, DJ1
Wang, Y1
Cardinal, JS1
Buchholz, BM1
Sugimoto, R1
Tobita, K1
Lee, S1
Toyoda, Y1
Billiar, TR1
McCurry, KR1
Szabo, G2
Romics, L2
Frendl, G2
Shi, Y1
Pan, F1
Li, H1
Pan, J1
Qin, S1
Jiang, D1
Shen, C1
Takahashi, T1
Morita, K1
Doctor, A1
Platt, R1
Sheram, ML1
Eischeid, A1
McMahon, T1
Maxey, T1
Doherty, J1
Axelrod, M1
Kline, J1
Gurka, M1
Gow, A1
Gaston, B1
Wunder, C1
Brock, RW1
Frantz, S1
Göttsch, W1
Morawietz, H1
Roewer, N1
Eichelbrönner, O1

Reviews

3 reviews available for carbon monoxide and Inflammatory Response Syndrome, Systemic

ArticleYear
Liver in sepsis and systemic inflammatory response syndrome.
    Clinics in liver disease, 2002, Volume: 6, Issue:4

    Topics: Apoptosis; Carbon Monoxide; Cholestasis; Cytokines; Heat-Shock Proteins; Hemodynamics; Humans; Lipop

2002
[Cellular and molecular changes of the liver in sepsis and in systemic inflammatory response syndrome (SIRS)].
    Orvosi hetilap, 2003, Mar-16, Volume: 144, Issue:11

    Topics: Acute-Phase Proteins; Animals; Apoptosis; Carbon Monoxide; Cytokines; Heat-Shock Proteins; Humans; L

2003
[The role of heat shock protein (HSP) in SIRS].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62, Issue:12

    Topics: Animals; Carbon Monoxide; Heat-Shock Proteins; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Oxida

2004

Other Studies

8 other studies available for carbon monoxide and Inflammatory Response Syndrome, Systemic

ArticleYear
Carbon monoxide-releasing molecule 2 inhibits inflammation associated with intestinal ischemia-reperfusion injury in a rat model of hemorrhagic shock.
    International immunopharmacology, 2022, Volume: 113, Issue:Pt B

    Topics: Animals; Carbon Monoxide; Cytokines; Inflammation; Interferon-gamma; Interleukin-17; Rats; Reperfusi

2022
Carbon monoxide-releasing molecule 2 inhibits inflammation associated with intestinal ischemia-reperfusion injury in a rat model of hemorrhagic shock.
    International immunopharmacology, 2022, Volume: 113, Issue:Pt B

    Topics: Animals; Carbon Monoxide; Cytokines; Inflammation; Interferon-gamma; Interleukin-17; Rats; Reperfusi

2022
Carbon monoxide-releasing molecule 2 inhibits inflammation associated with intestinal ischemia-reperfusion injury in a rat model of hemorrhagic shock.
    International immunopharmacology, 2022, Volume: 113, Issue:Pt B

    Topics: Animals; Carbon Monoxide; Cytokines; Inflammation; Interferon-gamma; Interleukin-17; Rats; Reperfusi

2022
Carbon monoxide-releasing molecule 2 inhibits inflammation associated with intestinal ischemia-reperfusion injury in a rat model of hemorrhagic shock.
    International immunopharmacology, 2022, Volume: 113, Issue:Pt B

    Topics: Animals; Carbon Monoxide; Cytokines; Inflammation; Interferon-gamma; Interleukin-17; Rats; Reperfusi

2022
Carbon monoxide-releasing molecule 2 inhibits inflammation associated with intestinal ischemia-reperfusion injury in a rat model of hemorrhagic shock.
    International immunopharmacology, 2022, Volume: 113, Issue:Pt B

    Topics: Animals; Carbon Monoxide; Cytokines; Inflammation; Interferon-gamma; Interleukin-17; Rats; Reperfusi

2022
Carbon monoxide-releasing molecule 2 inhibits inflammation associated with intestinal ischemia-reperfusion injury in a rat model of hemorrhagic shock.
    International immunopharmacology, 2022, Volume: 113, Issue:Pt B

    Topics: Animals; Carbon Monoxide; Cytokines; Inflammation; Interferon-gamma; Interleukin-17; Rats; Reperfusi

2022
Carbon monoxide-releasing molecule 2 inhibits inflammation associated with intestinal ischemia-reperfusion injury in a rat model of hemorrhagic shock.
    International immunopharmacology, 2022, Volume: 113, Issue:Pt B

    Topics: Animals; Carbon Monoxide; Cytokines; Inflammation; Interferon-gamma; Interleukin-17; Rats; Reperfusi

2022
Carbon monoxide-releasing molecule 2 inhibits inflammation associated with intestinal ischemia-reperfusion injury in a rat model of hemorrhagic shock.
    International immunopharmacology, 2022, Volume: 113, Issue:Pt B

    Topics: Animals; Carbon Monoxide; Cytokines; Inflammation; Interferon-gamma; Interleukin-17; Rats; Reperfusi

2022
Carbon monoxide-releasing molecule 2 inhibits inflammation associated with intestinal ischemia-reperfusion injury in a rat model of hemorrhagic shock.
    International immunopharmacology, 2022, Volume: 113, Issue:Pt B

    Topics: Animals; Carbon Monoxide; Cytokines; Inflammation; Interferon-gamma; Interleukin-17; Rats; Reperfusi

2022
Esterase-Sensitive and pH-Controlled Carbon Monoxide Prodrugs for Treating Systemic Inflammation.
    Journal of medicinal chemistry, 2019, 03-28, Volume: 62, Issue:6

    Topics: Animals; Carbon Monoxide; Esterases; Hydrogen-Ion Concentration; Mice; Prodrugs; RAW 264.7 Cells; Sy

2019
Carbon monoxide protects against hemorrhagic shock and resuscitation-induced microcirculatory injury and tissue injury.
    Shock (Augusta, Ga.), 2015, Volume: 43, Issue:2

    Topics: Animals; Carbon Monoxide; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Cytokines; Drug E

2015
Low-dose inhaled carbon monoxide attenuates the remote intestinal inflammatory response elicited by hindlimb ischemia-reperfusion.
    American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 296, Issue:1

    Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents; Carbon Monoxide; Cytokines; Disease M

2009
Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2010, Volume: 29, Issue:5

    Topics: Administration, Inhalation; Animals; Apoptosis; Blotting, Western; Carbon Monoxide; Cold Ischemia; D

2010
Carbon monoxide concentrations in paediatric sepsis syndrome.
    Archives of disease in childhood, 2003, Volume: 88, Issue:10

    Topics: Carbon Monoxide; Child; Child, Preschool; Female; Humans; Infant; Leukocyte Count; Male; Nitric Oxid

2003
Hemoglobin conformation couples erythrocyte S-nitrosothiol content to O2 gradients.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Apr-19, Volume: 102, Issue:16

    Topics: Animals; Biological Assay; Carbon Monoxide; Copper; Erythrocytes; Fluorescent Dyes; Hemoglobins; Hum

2005
Carbon monoxide, but not endothelin-1, plays a major role for the hepatic microcirculation in a murine model of early systemic inflammation.
    Critical care medicine, 2005, Volume: 33, Issue:10

    Topics: Animals; Carbon Monoxide; Disease Models, Animal; Endothelin-1; Liver; Liver Circulation; Male; Mice

2005